You need to enable JavaScript to view this site.Citing the tremendous cost of new drugs, an international group of biohackers say they are creating a knockoff of a million-dollar gene therapy.The drug being copied is Glybera, a gene therapy that was when it came on the market in Europe in 2015 with a price tag of $1 million per treatment. Glybera was the first gene therapy ever approved to treat an inherited disease.Now a band of independent and amateur biologists say they have engineered a prototype of a simpler, low-cost version of Glybera, and they plan to call on university and...…You need to enable JavaScript to view this site.Citing the tremendous cost of new drugs, an international group of biohackers say they are creating a knockoff of a million-dollar gene therapy.The drug being copied is Glybera, a gene therapy that was when it came on the market in Europe in 2015 with a price tag of $1 million per treatment. Glybera was the first gene therapy ever approved to treat an inherited disease.Now a band of independent and amateur biologists say they have engineered a prototype of a simpler, low-cost version of Glybera, and they plan to call on university and...WW…